Juine-ruey Chen

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccine.

Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccine.

Journal: Vaccine
Published: July 14, 2023

Safety Assessment of 3S, 3'S Astaxanthin Derived from Metabolically Engineered K. marxianus.

Safety Assessment of 3S, 3'S Astaxanthin Derived from Metabolically Engineered K. marxianus.

Journal: Antioxidants (Basel, Switzerland)
Published: October 21, 2022

Taiwan's Response to Influenza: A Seroepidemiological Evaluation of Policies and Implications for Pandemic Preparedness.

Taiwan's Response to Influenza: A Seroepidemiological Evaluation of Policies and Implications for Pandemic Preparedness.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 09, 2021

Better influenza vaccines: an industry perspective.

Better influenza vaccines: an industry perspective.

Journal: Journal of biomedical science
Published: December 05, 2019

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.

Journal: PloS one
Published: July 12, 2018

Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse.

Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse.

Journal: PloS one
Published: January 14, 2015

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 29, 2014

Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses.

Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses.

Journal: Vaccine
Published: October 30, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026